Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes.
Séjourné
F
F
Bioengineering Program, University of Illinois at Chicago 60612, USA.
Rubinstein
I
I
Suzuki
H
H
Alkan-Onyüksel
H
H
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002610:Cheek / Q000098:blood supply; D006224:Cricetinae; D004337:Drug Carriers; D005614:Freeze Fracturing; D008081:Liposomes; D008297:Male; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects; D013678:Technology, Pharmaceutical; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage* / Q000494:pharmacology
D004337:Drug Carriers; D008081:Liposomes; D014660:Vasoactive Intestinal Peptide